<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368626">
  <stage>Registered</stage>
  <submitdate>25/05/2015</submitdate>
  <approvaldate>12/06/2015</approvaldate>
  <actrnumber>ACTRN12615000615583</actrnumber>
  <trial_identification>
    <studytitle>Postoperative Recovery After Abdominal Hysterectomy: A Randomised Clinical Trial of Methadone Compared to Morphine</studytitle>
    <scientifictitle>A randomised blinded comparison of methadone to morphine in improving postoperative recovery and pain after total abdominal hysterectomy in adult women</scientifictitle>
    <utrn>U1111-1170-5633</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hysterectomy</healthcondition>
    <healthcondition>Pain after total abdominal hysterectomy</healthcondition>
    <healthcondition>Postoperative Recovery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intravenous methadone loading after anaesthetic induction:
Age 18-50	20mg
Age 50-70	15mg
Age 70-80	10mg

Intravenous methadone titration in the postoperative recovery room as per hospital morphine recovery protocol (equianalgesic dosing)

Morphine patient-controlled analgesia postoperatively: 1mg bolus, 5-minute lockout, no limit for at least 24 hours
</interventions>
    <comparator>Intravenous morphine loading after anaesthetic induction:
Age 18-50	20mg
Age 50-70	15mg
Age 70-80	10mg

Intravenous morphine titration in the postoperative recovery room as per hospital morphine recovery protocol

Morphine patient-controlled analgesia postoperatively: 1mg bolus, 5-minute lockout, no limit for at least 24 hours</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Quality of Recovery score (QoR-40)</outcome>
      <timepoint>24 hours after surgery completion</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>VAS pain scores at rest</outcome>
      <timepoint>1, 6, 24, 48 hours postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>VAS pain scores on movement</outcome>
      <timepoint>1, 6, 24, 48 hours postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Subjective analgesic efficacy
"How effective was your medication in relieving your pain over the last 24 h? (excellent, good, satisfactory, poor, very poor)</outcome>
      <timepoint>24, 48 hours postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Opioid received in recovery room (via record from nurse)</outcome>
      <timepoint>At discharge from recovery room</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to first PCA use (via PCA pump information)</outcome>
      <timepoint>At first PCA use</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total opioid use by patient-controlled analgesia (via PCA pump information)</outcome>
      <timepoint>1, 6, 24, 48 hours postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to discharge from hospital</outcome>
      <timepoint>Discharge from hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Chronic pain (worst NRS pain score in the last 24 hours assessed by phone interview)</outcome>
      <timepoint>3 months postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Nausea, vomiting, itch (0=none 1= mild 2= severe)</outcome>
      <timepoint>1, 6, 24, 48 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>g.	Sedation score (0=awake, alert 1=mild sedation, easy to rouse 2=moderate sedation, easy to rouse but unable to remain awake 3=difficult to rouse)</outcome>
      <timepoint>1, 6, 24, 48 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Respiratory rate (by clinical observation)</outcome>
      <timepoint>1, 6, 24, 48 hours</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Analgesics used in the previous 24 hours (verbal response assessed by phone interview)</outcome>
      <timepoint>3 months postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>If pain present, whether it is of new onset, or continuous since surgery, and whether pain is due to disease recurrence or surgical complications (verbal response assessed by phone interview)</outcome>
      <timepoint>3 months postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Pain comparator to preoperative state: less, same, or more pain compared to preoperatively (verbal response assessed by phone interview)</outcome>
      <timepoint>3 months postoperatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1.	ASA I, II or III
2.	Elective abdominal hysterectomy
3.	Age &lt; 80</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1.	Refusal to participate
2.	Unable to consent
3.	Non-English speaking background with inadequate spoken English to complete questionnaire
4.	Planned pelvic exenteration or radical hysterectomy
5.	Adverse drug reaction to morphine or methadone, or inability to receive a volatile anaesthetic
6.	Chronic pain, or taking any regular opioid or chronic pain medication preÂ­operatively (paracetamol, NSAIDs, or tramadol is not an exclusion criteria)
7.	History of intravenous drug use
8.	Preoperative renal failure (with eGFR &lt; 60 mL/min), known obstructive sleep apnoea, morbid obesity (BMI &gt; 40 kg/m2), or severe COAD (FEV1 &lt; 50% predicted)
9.	Use of CYP 2B6 inducers or inhibitors: rifampicin, antiepileptics (carbamazepine, phenobarbital, phenytoin), sertraline, antiplatelets (clopidogrel, prasugrel, ticlopidine), antivirals (efavirenz, nevirapine)
10.	Use of antipsychotic medication
11.	Patients with a prolonged QT interval (&gt; 440ms) on preoperative ECG
12.	Use of selective monoamine oxidase B inhibitors: selegiline, rasagiline</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelope with group allocation given to non-involved person to make up study drug. Anaesthetist, patient, nursing staff all blinded to allocation</concealment>
    <sequence>Randomised block design, stratified by incision type</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Two-sided Students t-tests will be used for all numerical data.
Fishers exact test will be used for categorical data.
Intention to treat analysis.
Missing data will not be imputed.

Sample size was calculated using published data on QoR-40 scores after abdominal hysterectomy, with a 10-point difference in QoR-40 being clinically significant (consistent with previous studies), alpha 0.05, beta 0.10.</statisticalmethods>
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>15/06/2015</anticipatedstartdate>
    <actualstartdate>27/07/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Monash Health</primarysponsorname>
    <primarysponsoraddress>246 Clayton Road
Clayton VIC 3168</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Monash Health</fundingname>
      <fundingaddress>246 Clayton Road
Clayton VIC 3168</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to compare the use of intravenous methadone to morphine in improving quality of recovery, acute pain and reducing the risk of chronic pain after abdominal hysterectomy.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Monash Health HREC</ethicname>
      <ethicaddress>Research Support Services
246 Clayton Road
Clayton VIC 3168</ethicaddress>
      <ethicapprovaldate>19/06/2015</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>2/06/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Josh Szental</name>
      <address>Department of Anaesthesia
Monash Medical Centre
246 Clayton Road
Clayton VIC 3168</address>
      <phone>+61395943283</phone>
      <fax />
      <email>jszental@gmail.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Josh Szental</name>
      <address>Department of Anaesthesia
Monash Medical Centre
246 Clayton Road
Clayton VIC 3168</address>
      <phone>+61395943283</phone>
      <fax />
      <email>jszental@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Josh Szental</name>
      <address>Department of Anaesthesia
Monash Medical Centre
246 Clayton Road
Clayton VIC 3168</address>
      <phone>+61395943283</phone>
      <fax />
      <email>jszental@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>